# Effects of the Ivabradine on Reduction of Inflammatory Markers in Patients With Acute Coronary Syndrome

> **NCT00815100** · PHASE4 · COMPLETED · sponsor: **Hospital Universitario de Canarias** · enrollment: 27 (actual)

## Conditions studied

- Acute Coronary Syndromes

## Interventions

- **DRUG:** Ivabradine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00815100
- **Lead sponsor:** Hospital Universitario de Canarias
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2011-04
- **Final completion:** 2011-09-07
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2020-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00815100

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00815100, "Effects of the Ivabradine on Reduction of Inflammatory Markers in Patients With Acute Coronary Syndrome". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00815100. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*